Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that it will conduct a reverse stock split of its outstanding shares of common stock, par value $0.001 per share

DEFT DEADLINE ALERT: DeFi Technologies Investors Urged to Contact Kirby McInerney LLP About Class Action Lawsuit

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Kirby McInerney LLP reminds DeFi Technologies ("DeFi" or the "Company") (NASDAQ:DEFT) investors of the January 30, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. If you purchased or otherwise acquired DeFi securities, have information, or would

Investigation Underway: Ramaco Resources, Inc. (METC) – Contact Levi & Korsinsky Over Securities Law Violations

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation into Ramaco Resources, Inc. ("Ramaco Resources, Inc.") (NASDAQ:METC) concerning potential violations of the federal securities laws. On October 23, 2025, Wolfpack Research released a report alleging that Ramaco’s rare earth’s project, Brook Mine,

Did You Lose Money on Telix Pharmaceuticals Ltd. (TLX)? Levi & Korsinsky Urges Investors to Act Before January 9, 2026

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Ltd. (NASDAQ:TLX) securities. If you suffered a loss on your Telix Pharmaceuticals Ltd. investment and would like to explore

Scroll to Top